Writing in Acta Pharmaceutica Sinica B, researchers explained how this could seriously affect intestinal function, increasing obstruction risk: "Because GLP-1RAs [GLP-1 receptor agonists] could cause continuous increases in the intestinal length and villus height, the small intestine may become as inelastic and fibrotic as a loose spring, leading to long-term upper intestinal obstruction " 60 Minutes covered the story of Trish Webster, a woman from Australia who died from an intestinal blockage after using Ozempic and Saxenda for five months
79 Efficient control of DM2 along with their effect on body mass index reduction and improvement of liver steatosis and steatohepatitis make them, for nonce, very attractive
Semaglutide and Tirzepatide, two groundbreaking medications in this class, have garnered attention for their remarkable efficacy in reducing body weight and addressing obesity-related comorbidities
Safe Medication Timing and Clinical Monitoring Strategies If your healthcare provider approves concurrent use, timing becomes critical
10.1007/s40265-022-01766-4 65 TeichN.MohlW.BokemeyerB.BndgensB.BningJ.MiehlkeS.et al (2016)
Strategies to manage them include: Start low, increase slowly: Begin with the lowest dose recommended by your licensed healthcare provider
